Jefferies Downgrades BeOne Medicines (ONC) to Hold

March 16, 2026 12:56 AM

Jefferies analyst Faisal Khurshid downgraded BeOne Medicines (NASDAQ: ONC) from Buy to Hold with a price target of $290.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found